Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$50,000.00
Aug 8, 2019
213836
213836
Engage expert wound care nurse consultant
$50,000.00
Jan 3, 2019
For-profit organization
Automation of Novel Allograft Processing/Packaging Unit for DermGEN™
918410
DermGEN™ has been developed as a novel decellularized allograft for the wound care market and is poised to commence commercial sales. DeCell Technologies proposal is to automate the decellularization process, using a closed system, dramatically reducing risks of contamination. Full automation of such a system has not been achieved by competing products, and would significantly differentiate DeCell Technologies platform from the competition as well as providing a significant cost advantage.
$140,019.00
Aug 6, 2015
$50,000.00
Jun 11, 2015
205531
205531
Hire a Chief Executive Officer
$276,000.00
Mar 25, 2014
203679
203679
Finalize scaled production and undertake initial marketing efforts
$500,000.00
Mar 25, 2014
203679
203679
Finalize scaled production and undertake initial marketing efforts
$37,495.00
May 13, 2013
202517
202517
Complete pre-clinical, conduct pilot manufacturing and prepare for clinical studies